Biotech Growth Investors & VC Firms

747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Radix Ventures 9 people · Follows rounds	Warsaw	PL	Seed–Late Stage	$550K – $2.8M	+ Add to CRM
Vision Incubate 9 people	Kanazawa	JP	Pre-Seed–Growth	—	+ Add to CRM
Korea Investment Partners 17 people	Seoul	KR	Seed–Late Stage	$973K – $50M	+ Add to CRM
PAI Partners 8 people	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
Salveo Capital 8 people	Northbrook	US	Seed–Late Stage	—	+ Add to CRM
Frontline Strategy Funds 2 people	Singapore	SG	Seed–Growth	$5M – $15M	+ Add to CRM
Flow Capital	Toronto	CA	Growth–Late Stage	—	+ Add to CRM
Prospect Venture Partners 3 people · Leads rounds	Menlo Park	US	Seed–Late Stage	$3M – $5M	+ Add to CRM
Aescap Life Sciences 14 people	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
Samho Green Investment, Inc. 11 people	Seoul	KR	Seed–Late Stage	$500K – $10M	+ Add to CRM
ALIVE Israel HealthTech Fund 10 people	Savyon	IL	Seed–Late Stage	—	+ Add to CRM
Evidity Health Capital 5 people	New York	US	Growth–Late Stage	$5M	+ Add to CRM
Outset Ventures 1 person · Leads rounds	Auckland	NZ	Pre-Seed–Growth	$100K – $10M	+ Add to CRM
6 Dimensions Capital 19 people	Grand Cayman	US	Seed–Late Stage	—	+ Add to CRM
Luma Group 13 people	Boston	US	Seed–Late Stage	—	+ Add to CRM
Pivotal Life Sciences 13 people	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
New Jersey Economic Development Authority 12 people	Trenton	US	Pre-Seed–Growth	—	+ Add to CRM
Recharge Thematic Ventures Management Llc 9 people · Leads rounds	New York	US	Seed–Late Stage	—	+ Add to CRM
Cardinal Partners 8 people · Leads rounds	Princeton	US	Seed–Growth	—	+ Add to CRM
Oita Venture Capital 1 person	Oita	JP	Pre-Seed–Growth	—	+ Add to CRM
Amathaon Capital 10 people	Munich	DE	Seed–Growth	$770K – $1.3M	+ Add to CRM
Sentica Partners Oy 10 people	Helsinki	FI	Growth	$1.1M – $10.8M	+ Add to CRM
Blackstone Life Sciences 9 people	New York	US	Series A–Late Stage	$20M – $60M	+ Add to CRM
BOLD Longevity 9 people · Follows rounds	Boston	US	Growth–Late Stage	—	+ Add to CRM